MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -57.5% | 24,067 | +8.5% | 0.00% | – |
| Q2 2023 | $73 | -27.7% | 22,187 | -9.8% | 0.00% | -100.0% |
| Q1 2023 | $101 | -26.8% | 24,589 | +4.1% | 0.00% | 0.0% |
| Q4 2022 | $138 | -99.9% | 23,612 | -7.5% | 0.00% | 0.0% |
| Q3 2022 | $172,000 | +266.0% | 25,514 | +114.4% | 0.00% | – |
| Q1 2022 | $47,000 | -29.9% | 11,902 | +10.0% | 0.00% | – |
| Q4 2021 | $67,000 | -96.6% | 10,819 | -91.2% | 0.00% | -100.0% |
| Q1 2021 | $1,989,000 | -45.5% | 122,938 | -10.4% | 0.01% | -50.0% |
| Q4 2020 | $3,649,000 | +41.9% | 137,141 | -0.7% | 0.02% | +29.4% |
| Q3 2020 | $2,571,000 | – | 138,097 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |